Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China flag China · Delayed Price · Currency is CNY
9.17
-0.03 (-0.33%)
Jun 6, 2025, 2:45 PM CST

Zhejiang Hisun Pharmaceutical Company Description

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China.

The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others.

The company also exports its products to approximately 70 countries worldwide. The company was founded in 1956 and is headquartered in Taizhou, China.

Zhejiang Hisun Pharmaceutical Co., Ltd.
Country China
Founded 1956
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 7,994
CEO Weihong Xiao

Contact Details

Address:
No. 46, Waisha Road
Taizhou, 318000
China
Phone 86 576 8882 7890
Website hisunpharm.com

Stock Details

Ticker Symbol 600267
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE0000013Z2
SIC Code 2833

Key Executives

Name Position
Weihong Xiao Chief Executive Officer and Chairman
Hong Shun Jin Senior Vice President
Zhiqing Yang Senior Vice President
Jiaqiu Du Senior Vice President and Director
Xi Fei Shen Ph.D. Secretary of the Board